Tea consumption, lipid metabolism, and atherosclerosis

Wiener Klinische Wochenschrift

Volumn 109, Issue 24, 1997, Pages 944-948

  Kritz, Harald ^b   Sinzinger, Helmut ^a,b,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b Withelm Auerswald ARG   (Austria)

^c Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

Author keywords

Atherosclerosis; Flavonoids; Hyperlipidemia; Tea

Indexed keywords

CAFFEINE; FLAVONOID;

ARTICLE; ATHEROSCLEROSIS; DIET SUPPLEMENTATION; DRINKING BEHAVIOR; HUMAN; HYPOLIPEMIA; LIPID METABOLISM; TEA;

ANIMALS; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; FLAVONOIDS; HUMANS; HYPERLIPIDEMIAS; TEA;

EID: 0031584570     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Young W, Hotovec RL, Romero AG (1967) Tea and atherosclerosis. Nature 216:1015-1016
2. Lou FQ (1979) On the strengthening of atherosclerosis research. Chung Hua Hsin Hsueh Kuan Ping Tsa Chih 7: 297-298
3. Lou FQ (1983) Effect of tea pigments on experimental atherosclerosis in rabbits and in treating patients with hyperfibrinogenemia. Chung Hua I Hsueh Tsa Chih 63: 632-634
4. Hertog MGL, Hollman PCH, Katan MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40: 2379-2383
5. Hertog MGL, Hollman PCH, van de Putte R (1993) Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric FoodChem 41: 1242-1246
6. Kühnau J (1976) The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24: 117-120
7. Deschner EE, Ruperto J, Wong G, Newmark HL (1991) Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogeneses 7: 1193-1196
8. Mukhtar H, Das M, Khan WA, Wang ZY, Bik DP, Bickers DR (1988) Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7, 12 dimethylbenz(a)anthrancene-. benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res 48: 2361-2365
9. Verma AK, Johnson JA, Gould MN, Tanner MA (1988) Inhibition of 7,12 dimethyl-benz(a)anthracene and N-nitrosomethylurea induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48: 5754-5758
10. Ranelletti FO, Ricci R, Larocca LM, Maggiano N, Capelli A, Scambra G, Benedetti-Panici P, Mancuso S, Rumi C, Piantelli M (1992) Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer 50: 486-492
11. Robak J, Gryglewski RJ (1988) Flavonoids are scavengers of superoxide anion. Biochem Pharmacol 37: 83-88
12. Husain SR, Cillard J, Cillard P (1987) Hydroxy radical scavenging activity of flavonoids. Phytochemistry 26: 2489-2492
13. Takahama U (1985) Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin: mechanism of antioxidative function. Phytochemistry 24: 1443-1446
14. De Whalley CV, Rankin SM, Hoult JRS, Jessup W, Leake DS (1990) Flavonoids inhibit the oxidative modification of low density lipoproteins. Biochem Pharmacol 39: 1743-1749
15. Negre-Salvayre A, Salvayre R (1992) Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radic Biol Med 12: 101-106
16. Kato L, Gozsy B (1970) Effets vasculaires des bioflavonoides chez le rat. Bordeaux Med 2: 438-446
17. Valensi P, Behar A, de Champvallins MM, Attalah M, Boulakia FC, Attali JR (1996) Effects of a purified micronized flavonoid fraction on capillary filtration in diabetic patients. Diabet Med 13: 882-888
18. Zemplenyi T, Fodor J, Lojda Z (1969) Mast cell histamine and the accumulation of colloidal particles in the vascular endothelium. Quart J Exp Physiol 45: 50-58
19. Robbins RC (1966) Effect of vitamin C and flavonoids on blood cell aggregation and capillary resistance. Int Z Vitaminforsch 36: 10-18
20. Robbins RC (1967) Effect of flavonoids on survival time of rats fed thrombogenic or atherogenic regimens. J Atheroscler Res 7: 3-10
21. Robbins RC (1971) Effects of phenyl benzo-pyrone derivatives (flavonoids) on blood cell aggregation: basis for a concept of mode of action. Clin Chem 5: 433-442
22. Cookson FB, Altschul R, Fedoroff S (1967) The effects of alfalfa on serum cholesterol and in modifying or preventing cholesterol-induced atherosclerosis in rabbits. J Atheroscler Res 7: 69-76
23. Howard AN (1984) Recent advances in nutrition and atherosclerosis. In: Jones RJ (ed) Atherosclerosis. Springer. Berlin Heidelberg New York, pp 46-50
24. Hornacek J, Trcka V, Vejdelek Z (1966) The effect of alfalfa extracts on experimental rabbit atherosclerosis. Czech Physiol 15: 33-39
25. Bickoff EM, Spencer RR, Knuckles BE, Lundin RE (1966) 3′-Methoxycoumestrol from alfalfa: isolation and characterization. Agricult Food Chem 14: 444-449
26. Halborg-Søerensen A, Hansen A (1970) Chronic venous insufficiency treated with hydroxyethylrutosides (HR). Angiologica 7: 192-196
27. Roztocil K, Fischer A, Novak P, Razgova L (1971) The effect of O-(β-hydroxyethyl)-rutosides (HR) on the peripheral circulation in patients with chronic venous insufficiency. Europ J Clin Pharmacol 3: 243-249
28. Prerovský I, Roztocil K, Hlavova A, Koleilat Z, Razgova L, Olivia I (1972) The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. Angiologica 9: 408-410
29. Lou F, Zhang M, Zhang X, Liu J, Yuan W (1989) A study on tea-pigment in prevention of atherosclerosis. Chin Med J 10: 579-583
30. Landolfi R, Mower RL, Steiner M (1984) Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem Pharmacol 33: 1525-1530
31. Sagesaka-Mitane Y, Miwa M, Okada S (1990) Platelet aggregation inhibitors in hot water extract of green tea. Chem Pharm Bull 38: 790-793
32. Corvazier E, Maclouf J (1985) Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochim Biophys Acta 835: 315-321
33. AH M, Afzal M (1987) A potent inhibitor of thrombin stimulated platelet thromboxane formation from unprocessed tea. Prostaglandins Leukotr Med 27: 9-13
34. Ali M, Afzal M, Gubler CJ, Burka JF (1990) A potent thromboxane formation inhibiton in green tea leaves. Prostaglandins Leukotr Essent Fatty Acids 40: 281-283
35. Muramatsu K, Fukuyo M, Hara Y (1986) Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 32: 613-622
36. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, et al. (1992) Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 127: 141-146
37. Yamaguchi Y, Hayashi M, Yamazoe H, Kunitono M (1991) Preventive effects of green tea extract on lipid abnormalities in serum, liver and aorta of mice fed and atherogenic diet. Nippon Yakurigaku Zasshi 97:329-337
38. Sheriff DS, el Fakhri M (1988) Tea consumption and serum lipids in a Libyan population in Benghazi. Ann Clin Biochem 25: 670-672
39. Green MS, Harari G (1992) Association of serum lipoproteins and health-related habits with coffee and tea consumption in free-living subjects examined in the Israeli CORDIS Study. Prev Med 21: 532-545
40. Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K (1992) Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med 21: 526-531
41. Stensvold I, Tverdal A, Solvoll K, Foss OP (1992) Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 21: 546-553
42. Brown CA, Bolton-Smith C, Woodward M, Tunstall-Pedoe H (1993) Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. J Epidemiol Community Health 47: 171-175
43. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet ii: 1007-1011
44. Hertog MGL, Feskens EJM, Hollman PCH, Kata MB, Kromhout D (1994) Dietary antioxidant flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 22: 175-184
45. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza R, et al. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381-386
46. Keli SO, Hertog MG, Feskens FJ, Kromhout D (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 156: 637-642
47. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC (1996) Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125: 384-389
48. Aro A, Kostiainen E, Huttunen JK, Seppala E, Vapaatalo H (1985) Effects of coffee and tea on lipoproteins and prostanoids. Atherosclerosis 57: 123-128
49. Kark JD, Friedlander Y, Kaufmann NA, Stein Y (1985) Coffee, tea, and plasma cholesterol: the Jerusalem Lipid Research Clinic prevalence study. BMJ 291: 699-704
50. Conney AH, Wang ZY, Huang MT, Ho CT, Yang CS (1992) Inhibitory effect of green tea on tumorogenesis by chemicals and ultraviolet light. Prev Med 21: 361-369
51. Imai K, Nakachi K (1995) Cross-sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310: 693-696
52. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet i: 454-457
53. Rice-Evans C (1995) Plant polyphenols: free radical scavengers or chain-breaking antioxidants? Biochem Soc Symp 61: 103-116